This most current twist inside the Lykos Therapeutics saga threatens a major overhaul of the business’s approach and path, with Musk ally and billionaire Trader Antonio Gracias showing up to choose to choose the corporation back again toward its nonprofit drug advancement roots and a more Doblinite philosophy.In many respects, the for-gain copyri